2025-03-17
The weight loss drug shortage is over — and some patients are 'panicking'
For Maria Rising, managing her health felt like chasing a phantom. The 30-year-old Lansing, Mich. consultant has for years battled polycystic ovary syndrome (PCOS) — a hormonal disorder that can cause weight fluctuations, insulin resistance, and in some cases debilitating pain.
[...]Rating
Innovation
Pricing
Technology
Usability
We have discovered similar tools to what you are looking for. Check out our suggestions for similar AI tools.
2025-05-01
VR is helping to make daunting medical treatments more bearable for patients
Stanley Johnson is not a fan of needles. The 67-year-old Air Force veteran has endured his fair share of pokes over the years, but when it was decided that IV infusions would be the best course of act [...]
2025-05-30
How Ozempic maker Novo Nordisk fell behind Eli Lilly in the weight loss drug race
Novo Nordisk (NVO) makes Ozempic, the best-known GLP-1 drug out today. And until quite recently, the Danish pharma giant consistently led the pack in new prescriptions, becoming virtually synonymous w [...]
2025-10-24
Mistral launches its own AI Studio for quick development with its European open source, proprietary models
The next big trend in AI providers appears to be "studio" environments on the web that allow users to spin up agents and AI applications within minutes. Case in point, today the well-funded [...]
2025-01-10
Verdiva launches with $410M for weight loss drugs to challenge Ozempic, Wegovy
London-headquartered biotech startup Verdiva has emerged from stealth with a whopping $410mn for a new range of drugs aimed at tackling the obesity epidemic. It’s one of Europe’s largest-ever biot [...]
2025-03-07
Wegovy's price cut, Amgen's Ozempic competitor, and Big Pharma's tax cut: Pharma news roundup
Novo Nordisk just cut the price of its weight-loss drug, Wegovy, by more than half for patients who pay without insurance. Amgen (AMGN) announced this week that it has begun two late-stage clinical tr [...]
2025-06-09
Pfizer, drug companies make 'no commitments' to White House about lowering drug prices
Cheaper pharmaceuticals won’t be on shelves any time soon, says the CEO of Pfizer. That’s despite an executive order signed last month declaring a war on drug prices, which at one point President [...]